GL1X · GenesisL1 explorer

MolNFT v1 · #81358 · protein

Crystal structure of the MALT1 paracaspase (P1 form)

3UO8 · Mucosa-associated lymphoid tissue lymphoma translocation…: “Crystal structure of the MALT1 paracaspase (P1 form)”. X-ray diffraction, 10 pockets (best druggability 0.85). MolNFT v1 #81358 on GenesisL1: 3D structure, binding sites…

PDB
3UO8
Type
protein
Length
735 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mucosa-associated lymphoid tissue lymphoma translocation protein 1…
EC
3.4.22.-
UniProt
Q9UDY8
Pockets
10 · best druggability 0.85

Structure

x-ray diffraction · 3 distinct chains · 21% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-)protein36422% helix, 30% strandQ9UDY8
CMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-)protein36321% helix, 29% strandQ9UDY8
L, MZ-val-arg-pro-dl-arg-fluoromethylketoneprotein40% helix, 50% strand—

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.850.9163empty
21190.560.8325empty
3650.560.8823empty
42140.520.7635empty
52070.500.7636empty

Interfaces

3 interfaces between chains.

  • B–C · 1385 Ų buried · 12 hydrogen bonds · protein-protein
  • C–M · 540 Ų buried · 15 hydrogen bonds · protein-protein
  • B–L · 536 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 3UO8 · Crystal structure of the MALT1 paracaspase (P1 form) · the same entry in another collection · chain B against B, TM-score 1.00
  • Q9UDY8 · AlphaFold monomer V2.0 prediction for mucosa-associated lymphoid tissue lymphoma… · a predicted model of the same protein · chain C against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.